|
NUDT19 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.394030E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.240900E-03 |
| Normal-vs-Stage2 |
8.686400E-02 |
| Normal-vs-Stage3 |
5.660400E-02 |
| Normal-vs-Stage4 |
5.234200E-01 |
| Stage1-vs-Stage2 |
7.869800E-01 |
| Stage1-vs-Stage3 |
7.291600E-01 |
| Stage1-vs-Stage4 |
2.076800E-01 |
| Stage2-vs-Stage3 |
6.570800E-01 |
| Stage2-vs-Stage4 |
2.772600E-01 |
| Stage3-vs-Stage4 |
3.518200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.588460E-02 |
| Normal-vs-AfricanAmerican |
6.662900E-03 |
| Normal-vs-Asian |
6.054500E-02 |
| Caucasian-vs-AfricanAmerican |
1.277780E-01 |
| Caucasian-vs-Asian |
2.882000E-02 |
| AfricanAmerican-vs-Asian |
1.437750E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.103200E-03 |
| Normal-vs-Female |
1.518970E-01 |
| Male-vs-Female |
1.773000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.826200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.218100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.851890E-02 |
| Normal-vs-Age(81-100Yrs) |
1.204280E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.862200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.303000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.543400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.489800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.262400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.935600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.559590E-02 |
| Normal-vs-Grade 2 |
2.860300E-02 |
| Normal-vs-Grade 3 |
4.076800E-03 |
| Normal-vs-Grade 4 |
9.412800E-01 |
| Grade 1-vs-Grade 2 |
1.037980E-01 |
| Grade 1-vs-Grade 3 |
2.053200E-01 |
| Grade 1-vs-Grade 4 |
1.097710E-02 |
| Grade 2-vs-Grade 3 |
5.029200E-01 |
| Grade 2-vs-Grade 4 |
1.040390E-01 |
| Grade 3-vs-Grade 4 |
3.925600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.359500E-03 |
| Normal-vs-ccB subtype |
6.775600E-01 |
| ccA subtype-vs-ccB subtype |
1.195540E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.014400E-02 |
| Normal-vs-N1 |
1.847610E-01 |
| N0-vs-N1 |
2.147600E-02 |
|
|
